Inhibitors of hepatitis C virus
Abstract:
Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0